<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nimkulrat SD</submitter><funding>NIDDK NIH HHS</funding><funding>NCRR NIH HHS</funding><pagination>2058-2066</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8576426</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>70(9)</volume><pubmed_abstract>Loss of mature β-cell function and identity, or β-cell dedifferentiation, is seen in both type 1 and type 2 diabetes. Two competing models explain β-cell dedifferentiation in diabetes. In the first model, β-cells dedifferentiate in the reverse order of their developmental ontogeny. This model predicts that dedifferentiated β-cells resemble β-cell progenitors. In the second model, β-cell dedifferentiation depends on the type of diabetogenic stress. This model, which we call the "Anna Karenina" model, predicts that in each type of diabetes, β-cells dedifferentiate in their own way, depending on how their mature identity is disrupted by any particular diabetogenic stress. We directly tested the two models using a β-cell-specific lineage-tracing system coupled with RNA sequencing in mice. We c</pubmed_abstract><journal>Diabetes</journal><pubmed_title>The Anna Karenina Model of β-Cell Maturation in Development and Their Dedifferentiation in Type 1 and Type 2 Diabetes.</pubmed_title><pmcid>PMC8576426</pmcid><funding_grant_id>S10 RR025483</funding_grant_id><funding_grant_id>R56 DK115837</funding_grant_id><pubmed_authors>Nimkulrat SD</pubmed_authors><pubmed_authors>Ni Z</pubmed_authors><pubmed_authors>Bernstein MN</pubmed_authors><pubmed_authors>Brown J</pubmed_authors><pubmed_authors>Kendziorski C</pubmed_authors><pubmed_authors>Blum B</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Anna Karenina Model of β-Cell Maturation in Development and Their Dedifferentiation in Type 1 and Type 2 Diabetes.</name><description>Loss of mature β-cell function and identity, or β-cell dedifferentiation, is seen in both type 1 and type 2 diabetes. Two competing models explain β-cell dedifferentiation in diabetes. In the first model, β-cells dedifferentiate in the reverse order of their developmental ontogeny. This model predicts that dedifferentiated β-cells resemble β-cell progenitors. In the second model, β-cell dedifferentiation depends on the type of diabetogenic stress. This model, which we call the "Anna Karenina" model, predicts that in each type of diabetes, β-cells dedifferentiate in their own way, depending on how their mature identity is disrupted by any particular diabetogenic stress. We directly tested the two models using a β-cell-specific lineage-tracing system coupled with RNA sequencing in mice. We c</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-18T18:43:02.071Z</modification><creation>2025-04-07T06:24:26.405Z</creation></dates><accession>S-EPMC8576426</accession><cross_references><pubmed>34417264</pubmed><doi>10.2337/db21-0211</doi></cross_references></HashMap>